These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8905180)

  • 21. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat parkinsonian model.
    Kim BG; Shin DH; Jeon GS; Seo JH; Kim YW; Jeon BS; Cho SS
    Brain Res; 2000 Feb; 855(1):162-5. PubMed ID: 10650144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
    Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.
    Oestreicher E; Sengstock GJ; Riederer P; Olanow CW; Dunn AJ; Arendash GW
    Brain Res; 1994 Oct; 660(1):8-18. PubMed ID: 7828004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra.
    He Y; Lee T; Leong SK
    Brain Res; 2000 Mar; 858(1):163-6. PubMed ID: 10700609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
    Costa G; Abin-Carriquiry JA; Dajas F
    Brain Res; 2001 Jan; 888(2):336-342. PubMed ID: 11150495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 6-OHDA injection on the AMPA glutamate receptor subunits in the substantia nigra of Sprague-Dawley rats.
    He Y; Lee T; Leong SK
    Neurosci Lett; 1998 Jan; 241(1):1-4. PubMed ID: 9502201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
    Xue YQ; Zhao LR; Guo WP; Duan WM
    Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system.
    Wang J; Jiang H; Xie JX
    Neurochem Res; 2004 Dec; 29(12):2239-43. PubMed ID: 15672545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autophagy is involved in 6-OHDA-induced dopaminergic cell death].
    Xia LP; Li LY; Fei XF; Liang ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2649-51. PubMed ID: 21177170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
    Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
    J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased energy expenditure and activated β3-AR-cAMP-PKA signaling pathway in the interscapular brown adipose tissue of 6-OHDA-induced Parkinson's disease model rats.
    Lian H; Zhou L; Zhang Y; Song YH; Zhang YM; Cao ZH; Wang ZY
    Anat Rec (Hoboken); 2021 Apr; 304(4):704-713. PubMed ID: 32865327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
    Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
    Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.
    Yue P; Gao L; Wang X; Ding X; Teng J
    Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.